On September 1, 2023, Forte Biosciences, Inc. announced that it has issued an investor presentation to its shareholders in connection with its 2023 annual shareholders meeting scheduled to be held on September 19, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5984 USD | +3.00% | -8.08% | -27.18% |
May. 30 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
May. 13 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.18% | 21.15M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences Issues an Investor Presentation to Shareholders